European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
J. Head. Pain; 20 (6), 2019
BACKGROUND AND AIM:
Monoclonal antibodies acting on the calcitonin gene-related peptide or on its receptor are new drugs to prevent migraine. Four monoclonal antibodies have been developed: one targeting the calcitonin gene-related peptide receptor (erenumab) and three targeting the calcitonin gene-relat...
Transtornos de Enxaqueca, Transtornos de Enxaqueca/diagnóstico, Transtornos de Enxaqueca/tratamento farmacológico, Transtornos de Enxaqueca/terapia, Transtornos de Enxaqueca/prevenção & controle, Receptores de Peptídeo Relacionado com o Gene de Calcitonina/uso terapêutico, Peptídeo Relacionado com Gene de Calcitonina/uso terapêutico, Cefaleia, Cefaleia/tratamento farmacológico, Cefaleia/diagnóstico, Cefaleia/terapia, Cefaleia/prevenção & controle